振荡式全身振动改善肺动脉高压患者的运动能力和体能:一项随机临床研究
22例WHO功能II或III级、稳定靶向治疗≥3个月的肺动脉高压患者随机接受4周16次全身振动或对照后交叉,6分钟步行距离净获益39.7±7.8米(p=0.004),心肺运动试验、肌力和生活质量亦改善,未发生操作相关严重不良事件。
要点
- 全身振动组6分钟步行距离较对照组净获益39.7±7.8米(p=0.004)。
- 全部患者合并分析示6分钟步行距离较基线增加38.6米,峰值摄氧量增加65.7 mL/min。
- 全身振动耐受良好,无操作相关严重不良事件。
核心结论
- 全身振动可显著改善稳定靶向治疗的肺动脉高压患者的运动能力、体能和生活质量。
- 作者认为该方法可用于结构化训练方案,并可能适合这些患者长期持续体能锻炼。
研究设计与样本
- 随机临床研究,22例肺动脉高压患者(平均肺动脉压≥25 mm Hg且肺动脉楔压≤15 mm Hg,WHO功能II或III级,稳定靶向治疗≥3个月)。
- 随机接受全身振动(4周内16次、每次1小时)或对照组(随后接受全身振动)。
- 随访指标包括6分钟步行距离、心肺运动试验、超声心动图、肌力和健康相关生活质量(SF-36和LPH问卷)。
主要发现
- 与对照组相比,全身振动组主要终点6分钟步行距离显著改善(+35.4±10.9 vs -4.4±7.6米),净获益39.7±7.8米(p=0.004)。
- 全身振动还与心肺运动试验变量、肌力和生活质量的显著改善相关。
- 全部患者(n=22)合并分析示较基线显著净改善:6分钟步行距离+38.6米、峰值摄氧量+65.7 mL/min、无氧阈+40.9 mL VO2/min、肌力+4.4%、SF-36 +9.7分、LPH -11.5分(均p<0.05)。
- 全身振动在所有患者中耐受良好,未发生操作相关严重不良事件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients with pulmonary arterial hypertension (PAH), supportive therapies may be beneficial in addition to targeted medical treatment. Here, we evaluated the effectiveness and safety of oscillatory whole-body vibration (WBV) in patients on stable PAH therapy. METHODS: Twenty-two patients with PAH (mean PAP≥25 mm Hg and pulmonary arterial wedge pressure (PAWP)≤15 mm Hg) who were in world health organization (WHO)-Functional Class II or III and on stable PAH therapy for≥3 months, were randomised to receive WBV (16 sessions of 1-hour duration within 4 weeks) or to a control group, that subsequently received WBV. Follow-up measures included the 6-min walking distance (6MWD), cardiopulmonary exercise testing (CPET), echocardiography, muscle-power, and health-related quality of life (HRQoL; SF-36 and LPH questionnaires). RESULTS: When compared to the control group, patients receiving WBV exhibited a significant improvement in the primary endpoint, the 6MWD (+35.4±10.9 vs -4.4±7.6 m), resulting in a net benefit of 39.7±7.8 m (p=0.004). WBV was also associated with substantial improvements in CPET variables, muscle power, and HRQoL. The combined analysis of all patients (n=22) indicated significant net improvements versus baseline in the 6MWD (+38.6 m), peakVO2 (+65.7 mL/min), anaerobic threshold (+40.9 mL VO2/min), muscle power (+4.4%), and HRQoL (SF-36 +9.7, LPH -11.5 points) (all p<0.05). WBV was well tolerated in all patients, and no procedure-related severe adverse events (SAEs) occurred. CONCLUSIONS: WBV substantially improves exercise capacity, physical performance, and HRQoL in patients with PAH who are on stable targeted therapy. This methodology may be utilised in structured training programmes, and may be feasible for continuous long-term physical exercise in these patients. TRIAL REGISTRATION NUMBER: NCT01763112; Results.
引用
- Gerhardt F, Dumitrescu D, Gärtner C, et al. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study. Heart. 2017. PMID: 28100544. doi:10.1136/heartjnl-2016-309852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。